Trial intelligence / Profile preview

BioZ study in psoriasis: biologics during pregnancy immune profiling

NL-OMON57075Recruiting

Sponsor
Radboud University Medical Center
Start
Jun 2025
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label trial of adalimumab, certolizumab pegol, ustekinumab, ixekizumab, guselkumab and 1 more in plaque psoriasis and psoriasis (4 arms), sponsored by Radboud University Medical Center. Started Jun 2025; status: recruiting.

02

Drugs

adalimumabcertolizumab pegolustekinumabixekizumabguselkumab
03

Conditions

plaque psoriasispsoriasis

Beyond the preview

Go deeper on NL-OMON57075.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON57075.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call